Drug recall
Apheresis Platelets, Leukocytes Reduced
FDA recall event 99645 · Class III · HCSC-Blood Center
Key facts
| Event ID | 99645 |
|---|---|
| Recall numbers | B-0239-2026 |
| Recalling firm | HCSC-Blood Center |
| Product type | Biologics |
| Products | Apheresis Platelets, Leukocytes Reduced |
| Classification | Class III |
| Status | Terminated |
| Voluntary or mandated | Voluntary: Firm Initiated |
| Reason for recall | Apheresis Platelets, Leukocytes Reduced, which were exposed to unacceptable storage temperatures, were distributed. |
| Initiation date | Jul 9, 2025 |
| Report date | Sep 30, 2026 |
| Termination date | Sep 21, 2026 |
| City | Bethlehem |
| State | PA |
| Country | United States |
| FEI number | 2573135 |
At a glance
- 1–9 Products in this recall
- 10–99 FDA inspections of this firm (FEI)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug and product recalls
FDA enforcement reports list recalls of drugs, biologics, foods and other FDA-regulated products, classified by the potential health hazard.
Source: U.S. Food and Drug Administration (FDA), Enforcement Reports · Source date: